Skip to main content
Patient Education
Heart & VascularBlog SeriesWhen Sepsis, Renal Failure, Respiratory Compromise and Encephalopathy Converge./Part 8

Integrated Multiorgan Dysfunction, Terminal Clinical Course and Outcome. — Part 8

Explore the final clinical course and outcome of a patient with MDR E. coli urosepsis and progressive multiorgan dysfunction, with key critical care insights.

Dr. Rohit tiwari
4 Nov 2026
6 min read
Medically reviewed
Integrated Multiorgan Dysfunction, Terminal Clinical Course and Outcome. — Part 8


 Part 8 of 8


Integrated Multiorgan Dysfunction, Terminal Clinical Course and Outcome


When Sepsis, Renal Failure, Respiratory Compromise and Encephalopathy Converge


Introduction


The preceding seven parts of this series have traced the clinical journey of an elderly patient whose initial cardiovascular presentation evolved into a complex critical illness involving multidrug-resistant (MDR) Escherichia coli urosepsis, acute kidney injury on chronic kidney disease, respiratory failure, cardiac rhythm disturbances, neurological deterioration and significant hematological complications.


As explored in Part 7, the patient's condition was further complicated by recurrent severe hypercapnic respiratory failure, a near-arrest episode and hemodynamic instability. Despite ongoing critical care support and multidisciplinary involvement, the overall clinical course remained challenging.


This final part brings together the subsequent clinical developments, focusing on the convergence of multiorgan dysfunction, the terminal phase of illness and the documented outcome. It also examines the broader clinical lessons emerging from the patient's course, emphasizing why individual improvements must always be interpreted in the context of overall physiological stability.


Clinical Course: Progression to Terminal Multiorgan Dysfunction


1. Evolution of Multiorgan Dysfunction


The patient's illness began with chest discomfort, vomiting, shivering and severe hypertension. Initial cardiovascular assessment showed a left ventricular ejection fraction of approximately 55%, without regional wall-motion abnormalities.


Further investigations identified urinary infection associated with MDR Escherichia coli, with an acute deterioration in renal function on a background of chronic kidney disease.


The infection and associated renal dysfunction established the foundation for a progressively complicated hospital course. As described in Parts 1 and 2, the patient required antimicrobial management and repeated renal support, including five hemodialysis sessions.


2. Respiratory and Cardiovascular Complications


The clinical course subsequently involved bilateral infective-inflammatory pulmonary opacities, pleural effusions and hypercapnic respiratory failure requiring non-invasive ventilatory support.


As discussed in Parts 3 and 7, respiratory deterioration was recurrent. Despite periods of improvement, the patient later required continuous NIV following a severe episode of hypercapnia.


Cardiovascular complications included atrial fibrillation with a fast ventricular response, while recurrent hypokalemia added further complexity to the clinical picture.


Important clinical distinction: The HD16 near-arrest episode, described in Part 7, represented a major deterioration during this phase. However, this event must be distinguished from the separately documented terminal cardiac arrest on HD18.


3. Neurological and Hematological Deterioration


Neurological dysfunction developed during the course of critical illness. Elevated ammonia levels were documented, and the encephalopathy was considered multifactorial in the setting of sepsis and metabolic disturbances.


As described in Part 6, the available clinical findings did not establish a single definitive mechanism for the neurological impairment.


The later course was also complicated by candiduria, thrombocytopenia, anemia and significant coagulation abnormalities. Candida albicans was isolated from urine culture, while subsequent investigations demonstrated prolonged coagulation parameters, falling fibrinogen and markedly abnormal thromboelastography findings.


Oral and nasal bleeding were followed by melena, indicating further hematological and gastrointestinal complications during an already critical phase.


4. Terminal Clinical Phase


During the terminal phase, the patient continued to require continuous NIV and remained clinically compromised, with profound hypercapnia, persistent neurological impairment, unstable renal indices and significant hematological abnormalities.


Coagulopathy and gastrointestinal bleeding further complicated management. The patient's care involved multidisciplinary input from Cardiology/CCU, Nephrology, Pulmonology, Neurology, Gastroenterology and Microbiology.


The family was repeatedly counselled regarding the patient's deterioration and prognosis. DNI/DNR-related decisions were documented, and endoscopy was deferred.


5. Documented Outcome


On day 18 (HD18), the patient experienced cardiac arrest at approximately 14:00. Return of spontaneous circulation (ROSC) was not achieved. The ECG showed asystole, and death was declared at 14:31.


The treating-team summary attributed the death to septic shock with multiorgan dysfunction associated with MDR E. coli urosepsis, accompanied by major renal, respiratory, hematological and bleeding complications.


Discussion: Understanding the Convergence of Organ Dysfunction


This case demonstrates how severe infection can evolve into a complex critical illness involving multiple interconnected organ systems.


The clinical journey across all eight parts highlights several important considerations:


  1. Diagnostic evolution and infection: The initial cardiovascular presentation was followed by evidence of MDR E. coli urinary-source infection, emphasizing the importance of reassessing the diagnosis as new clinical information emerges.

  2. Renal dysfunction and dialysis: AKI on CKD required repeated hemodialysis. Renal laboratory values must be interpreted in relation to dialysis timing and the broader clinical condition rather than being considered independent evidence of renal recovery.

  3. Respiratory instability: The progression from intermittent NIV to continuous ventilatory support illustrates the importance of monitoring the overall respiratory trajectory. Improvement in an individual blood gas parameter does not independently establish clinical recovery.

  4. Cardiovascular and electrolyte complications: Atrial fibrillation and recurrent hypokalemia added further challenges during the course of severe infection and multiorgan dysfunction.

  5. Multifactorial neurological impairment: Encephalopathy occurred in the setting of sepsis and metabolic disturbances. Elevated ammonia was documented, but the available findings do not establish a single cause.

  6. Coagulopathy and bleeding: Thrombocytopenia, prolonged coagulation parameters, falling fibrinogen and gastrointestinal bleeding complicated the terminal phase. These findings demonstrate the importance of evaluating the broader coagulation profile rather than relying on INR alone.

  7. Multidisciplinary critical care: The involvement of multiple specialties reflected the complexity of managing simultaneous renal, respiratory, cardiovascular, neurological and hematological complications.

  8. Key Clinical Learning Points


    • Severe infection can progress beyond its initial site and involve multiple organ systems.
    • Renal function trends in patients receiving dialysis must be interpreted in relation to the timing of renal replacement therapy.
    • Improvement in blood gas parameters does not necessarily indicate overall respiratory or clinical recovery.
    • Recurrent electrolyte disturbances and cardiac rhythm abnormalities can complicate the management of critically ill patients.
    • Encephalopathy may be multifactorial, and individual laboratory abnormalities should not be treated as proof of a single mechanism.
    • Coagulation abnormalities require assessment of multiple parameters, including platelet count, PT/INR, aPTT, fibrinogen and available viscoelastic findings.
    • Accurate documentation of clinical deterioration, terminal events and limitations of care is essential in complex critical care cases.

    • Conclusion


      This eight-part clinical series illustrates the progression of MDR Escherichia coli urosepsis into severe multiorgan dysfunction involving renal, respiratory, cardiovascular, neurological and hematological complications.


      The patient's course highlights the challenges of managing overlapping organ dysfunction, interpreting changing clinical parameters and reassessing the overall trajectory despite ongoing supportive treatment.


      The documented terminal outcome underscores the severity of the illness and the importance of multidisciplinary critical care, continuous reassessment and accurate clinical documentation.


      Ultimately, this case reinforces an important principle: clinical improvement in one organ system or laboratory parameter must always be interpreted within the context of the patient's overall physiological condition.



      Patient Privacy 

      This case is presented in de-identified form for medical education. Patient identity and potentially identifying details have been masked or generalized to preserve confidentiality. Publication is subject to applicable patient-consent, privacy and institutional requirements.


      Clinical Education Disclaimer

      This article is intended solely for medical education and professional clinical discussion. It presents a documented clinical case and its associated learning points. It does not constitute medical advice, establish a universal treatment protocol or replace individualized patient assessment, professional clinical judgment or specialist consultation.